# EDGAR Filing Document

**Accession Number:** 0001847846
**File Stem:** 0001493152-26-009002
**Filing Date:** 2026-3
**Character Count:** 7709
**Document Hash:** 9336a65123460cbcaed71d60ab454a03
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001493152-26-009002.hdr.sgml**: 20260305

**ACCESSION NUMBER**: 0001493152-26-009002

**CONFORMED SUBMISSION TYPE**: 6-K

**PUBLIC DOCUMENT COUNT**: 41

**CONFORMED PERIOD OF REPORT**: 20260228

**FILED AS OF DATE**: 20260305

**DATE AS OF CHANGE**: 20260305

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** EUDA Health Holdings Ltd
- **CENTRAL INDEX KEY:** 0001847846
- **STANDARD INDUSTRIAL CLASSIFICATION:** SERVICES-HEALTH SERVICES [8000]
- **ORGANIZATION NAME:** 08 Industrial Applications and Services
- **EIN:** 000000000
- **STATE OF INCORPORATION:** D8
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 6-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-40678
- **FILM NUMBER:** 26726622

**BUSINESS ADDRESS:**
- **ADDRESS IS A NON US LOCATION:** YES
- **STREET 1:** 60 KAKI BUKIT PLACE, #03-01
- **CITY:** EUNOS TECHPARK
- **PROVINCE COUNTRY:** U0
- **ZIP:** 415979
- **BUSINESS PHONE:** 65 67880388

**MAIL ADDRESS:**
- **ADDRESS IS A NON US LOCATION:** YES
- **STREET 1:** 60 KAKI BUKIT PLACE, #03-01
- **CITY:** EUNOS TECHPARK
- **PROVINCE COUNTRY:** U0
- **ZIP:** 415979

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** 8i Acquisition 2 Corp.
- **DATE OF NAME CHANGE:** 20210224

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

**Form 6-K**

**REPORT OF FOREIGN PRIVATE ISSUER**

**PURSUANT TO RULE 13a-16 OR 15d-16**

**UNDER THE SECURITIES EXCHANGE ACT OF 1934**

**For the month of February 2026**

**Commission File Number: 001-40678**

**EUDA Health Holdings Limited**

(Exact Name of Registrant as Specified in its Charter)

60 Kaki Bukit Place, #03-01 Eunos Techpark, Singapore 415979

(Address of Principal Executive Offices and Zip Code)

Registrant's telephone number, including area code: +65 6327 1110

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F. Form 20-F ☒ Form 40-F ☐

On February 27, 2026, EUDA Health Holdings Limited, a company incorporated in the British Virgin Islands (the "Company"), filed an Amended and Restated Memorandum and Articles of Association (the "A&R Charter") with the BVI Registrar of Corporate Affairs, to, among other things, set out the Company's ability to divide or combine its ordinary shares, including the ability to effect a share combination by way of resolution of directors or resolution of members. A copy of the A&R Charter is filed as Exhibit 3.1 to this Current Report on Form 6-K and is incorporated herein by reference.

On March 4, 2026, EUDA Health Holdings Limited issued the press release filed herewith as Exhibit 99.1.

This Report on Form 6-K is incorporated by reference into the Company's Registration Statement on Form F-3 (File No. [333-282723](https://www.sec.gov/Archives/edgar/data/1847846/000149315224041563/formf-3.htm)) and the prospectus thereof and any prospectus supplements or amendments thereto.

**Exhibits**

3.1 [Amended and Restated Memorandum and Articles of Association dated as of February 27, 2026.](ex3-1.htm)

99.1 [Press release dated March 4, 2026](ex99-1.htm)

**SIGNATURES**

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.

---

| | |
|:---|:---|
| Dated: March 5, 2026 | Dated: March 5, 2026 |
| **EUDA Health Holdings Limited** | **EUDA Health Holdings Limited** |
|  | */s/ Alfred Lim* |
| By: | Alfred Lim |
|  | Chief Executive Officer |

---

## Exhibit 3.1

**Exhibit 3.1**

![](ex3-1_001.jpg)

![](ex3-1_002.jpg)

![](ex3-1_003.jpg)

![](ex3-1_004.jpg)

![](ex3-1_005.jpg)

![](ex3-1_006.jpg)

![](ex3-1_007.jpg)

![](ex3-1_008.jpg)

![](ex3-1_009.jpg)

![](ex3-1_010.jpg)

![](ex3-1_011.jpg)

![](ex3-1_012.jpg)

![](ex3-1_013.jpg)

![](ex3-1_014.jpg)

![](ex3-1_015.jpg)

![](ex3-1_016.jpg)

![](ex3-1_017.jpg)

![](ex3-1_018.jpg)

![](ex3-1_019.jpg)

![](ex3-1_020.jpg)

![](ex3-1_021.jpg)

![](ex3-1_022.jpg)

![](ex3-1_023.jpg)

![](ex3-1_024.jpg)

![](ex3-1_025.jpg)

![](ex3-1_026.jpg)

![](ex3-1_027.jpg)

![](ex3-1_028.jpg)

![](ex3-1_029.jpg)

![](ex3-1_030.jpg)

![](ex3-1_031.jpg)

![](ex3-1_032.jpg)

![](ex3-1_033.jpg)

![](ex3-1_034.jpg)

![](ex3-1_035.jpg)

![](ex3-1_036.jpg)

![](ex3-1_037.jpg)

![](ex3-1_038.jpg)

## Exhibit 99.1

**Exhibit 99.1**

**EUDA Health Holdings Limited Announces Repurchase and Cancellation of Streeterville Warrant**

SINGAPORE, March 04, 2026 (GLOBE NEWSWIRE) — EUDA Health Holdings Limited (NASDAQ: EUDA) ("EUDA" or the "Company"), a Singapore based non-invasive healthcare provider in Asia focused on Singapore, Malaysia and China, today announced that it has repurchased and cancelled in full the warrant previously issued to Streeterville Capital, LLC.

**Background of the Warrant**

As previously disclosed, the Company entered into a securities purchase agreement dated November 26, 2025 with an accredited investor for the purchase of a warrant that was immediately exercisable into up to 2,000,000 newly issued ordinary shares of the Company. The warrant was previously amended on December 16, 2025 and January 13, 2026.

**Repurchase and Cancellation**

On February 27, 2026, the Company repurchased the warrant in full for a total purchase price of US$125,000. Following the repurchase, the warrant was cancelled and is no longer outstanding.

As a result of this transaction, there are no warrants remaining under this agreement, and the potential issuance of shares associated with the warrant has been fully eliminated.

**About EUDA Health Holdings Limited**

EUDA Health Holdings Limited (NASDAQ: EUDA) is a Singapore-based leading non-invasive healthcare provider in Asia with a focus on Singapore, Malaysia and China. The Company aims to become a market leader in non-invasive and preventive healthcare, with a strategic focus on the fast-growing longevity sector. Our mission is to address the evolving healthcare needs of over 1.8 billion people across the region which is experiencing significant demographic shifts as more than 30% of the population ages rapidly. By offering innovative, accessible, and science-backed health solutions, EUDA is positioned to lead the transformation of regional healthcare from reactive medical treatment to proactive, longevity-focused care. EUDA also runs a Singapore-based property management business.

**Forward-Looking Statements**

This document may contain forward-looking statements regarding risks and uncertainties. These statements usually use forward-looking words, such as the words "estimates," "projected," "expects," "envisions," "anticipates," "forecasts," "plans," "intends," "believes," "seeks," "may," "will," "should," "future," "propose" and variations of these words or similar expressions (or the negative versions of such words or expressions). These forward-looking statements are not guarantees of future performance, conditions or results, and involve a number of known and unknown risks, uncertainties, assumptions and other important factors, many of which are outside EUDA's control, that could cause actual results or outcomes to differ materially from those discussed in the forward-looking statements. You should not overly rely on forward-looking statements that are only applicable to the date of publication of this document. The Company does not undertake any obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

*Christensen Advisory*

 

*Christian Arnell<br> Phone: +852 2117 0861<br> Email: christian.arnell@christensencomms.com*